These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1094037)

  • 1. Pharmacokinetic data and drug monitoring: I. Antibiotics and antiarrhythmics.
    Chow MS; Ronfeld RA
    J Clin Pharmacol; 1975; 15(5-6):405-18. PubMed ID: 1094037
    [No Abstract]   [Full Text] [Related]  

  • 2. Disopyramide phosphate: pharmacokinetic and pharmacologic relationships of a new antiarrhythmic agent.
    Ranney RE; Dean RR; Karim A; Radzialowski FM
    Arch Int Pharmacodyn Ther; 1971 May; 191(1):162-88. PubMed ID: 4104224
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacokinetics of creatinol-o-phosphate].
    Marzo A; Ghirardi P; Croce G
    Clin Ter; 1972 Sep; 62(5):419-30. PubMed ID: 5085247
    [No Abstract]   [Full Text] [Related]  

  • 4. Dosage regimens of antiarrhythmics. 1. Pharmacokinetic properties.
    Levy RH; Smith GH
    Am J Hosp Pharm; 1973 May; 30(5):398-404. PubMed ID: 4704419
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacokinetics of anti-arrhythmics. 1. Fundamental principles].
    Lévy RH
    Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1223-8. PubMed ID: 6778415
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical pharmacokinetics of some antiarrhythmic drugs.
    Ochs HR; Greenblatt DJ; Bodem G
    Herz; 1979 Aug; 4(4):330-43. PubMed ID: 391683
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors involved in the choice of routes of administration of antimicrobial drugs.
    Baggot JD
    J Am Vet Med Assoc; 1984 Nov; 185(10):1076-82. PubMed ID: 6392233
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacokinetics of antibiotics as a basis for their dosage in children].
    Poliak MS
    Antibiot Med Biotekhnol; 1986 Jan; 31(1):67-75. PubMed ID: 3511840
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical pharmacokinetics of digitoxin.
    Perrier D; Mayersohn M; Marcus FI
    Clin Pharmacokinet; 1977; 2(4):292-311. PubMed ID: 902449
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug kinetics and artificial kidneys.
    Gibson TB; Nelson HA
    Clin Pharmacokinet; 1977; 2(6):403-26. PubMed ID: 22417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic study of aprindine and moxaprindine in dogs.
    de Suray JM; Lavis A; Breekpot F
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):209-15. PubMed ID: 7251236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of pharmacokinetics in the design of fixed-ratio antibiotic combinations.
    Brumfitt W; Hamilton-Miller JM
    G Ital Chemioter; 1979; 26(1-2):407-12. PubMed ID: 400152
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetic profile of sulfisoxazole following intravenous, intramuscular, and oral administration to man.
    Kaplan SA; Weinfeld RE; Abruzzo CW; Lewis M
    J Pharm Sci; 1972 May; 61(5):773-8. PubMed ID: 5035788
    [No Abstract]   [Full Text] [Related]  

  • 14. Kinetics of the oral antiarrhythmic lidocaine congener, tocainide.
    Lalka D; Meyer MB; Duce BR; Elvin AT
    Clin Pharmacol Ther; 1976 Jun; 19(6):757-66. PubMed ID: 1269216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bicyclomycin, a new antibiotic. IV. Absorption, excretion and tissue distribution.
    Nishida M; Mine Y; Matsubara T; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1972 Oct; 25(10):594-601. PubMed ID: 4648313
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics in man of a new antiarrhythmic drug, cibenzoline.
    Canal M; Flouvat B; Tremblay D; Dufour A
    Eur J Clin Pharmacol; 1983; 24(4):509-15. PubMed ID: 6861865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Route of antibiotics administration].
    Segev S; Rubinstein E
    Harefuah; 1986 Jan; 110(2):101-3. PubMed ID: 3699597
    [No Abstract]   [Full Text] [Related]  

  • 18. [Importance of pharmacokinetic studies in the clinical phase of experimentation with anti-arrhythmia agents].
    Jaillon P
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():57-64. PubMed ID: 6803702
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetic investigations of Craviten. III. Tissue distribution and elimination in rats.
    Danek A; Witek J
    Pol J Pharmacol Pharm; 1980; 32(6):941-8. PubMed ID: 7243691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fate of SU-13197, a new antiarrhythmic drug, in rat and man.
    Shand DG; Cavanaugh JH; Oates JA
    Clin Pharmacol Ther; 1971; 12(5):769-78. PubMed ID: 5568258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.